Treatment-Shortening Effect of a Novel Regimen Combining High-Dose Rifapentine and Clofazimine in Pathologically Distinct Mouse Models of Tuberculosis

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00388-19

Related search